HomeOpen Access NewsContributor Profile

Contributor Profile

Full fibre connectivity: What you need to know before you buy

Dominic Norton from Spitfire Network Services emphasises the importance of understanding the differences in fibre connectivity, highlighting the need to discern variations in quality and technology, while cautioning consumers against making choices based solely on price.

Is smart working heralding the slow ‘death’ of the traditional office?

Alison White, co-founder of PLACEmaking, shares her thoughts on the extent to which modern working practices are slowly eroding the outdated office culture of previous generations

Universal health coverage in Africa and the public good

Associate Professor at University of Oslo, Dr Ruth J. Prince provides an overview of universal health coverage (UHC) and why this is important in Africa when it comes to the state, citizenship, healthcare and welfare

Reinventing the collaborative economy with blockchain

The ERC research project P2P Models aims to use blockchain-driven Decentralized Autonomous Organizations (DAOs) to boost a collaborative economy which is decentralised, democratic and where profits are distributed, as the university’s researcher, Professor Samer Hassan reveals

Escherichia coli evolution from the lab, to the mice gut and the wild

Professor Olivier Tenaillon from IAME -INSERM outlines the evolution of Escherichia coli (E. coli) from the lab, to the mice gut and the wild

Do we know what red blood cells look like?

Anna Bogdanova, Professor and Head of Red Blood Cell Research Group at the University of Zurich explains how we know how red blood cells look like and if so, what they tell us

How is blockchain disrupting health and wellness?

Distributed and open technologies are bringing new business models, personalisation, prediction, motivation, collaboration and trust in healthcare, in the view of Sari Stenfors from the ReCon Blockchain Research Project, at Aalto University in Finland

Assessing endocrine disrupting chemicals (EDC)

Alberto Mantovani presents the contribution of the Istituto Superiore di Sanità (ISS) to the international assessment of endocrine disrupting chemicals (EDC)

The importance of animal welfare: European precision and sustainable livestock farming

Daniel Berckmans and Tomas Norton from M3-BIORES, Catholic University of Leuven together explore the importance of animal welfare and livestock farming in Europe

Diabetes & peripheral arterial disease

A change of paradigm improves patients’ outcomes with diabetes & peripheral arterial disease, according to the Division of Angiology at the Medical University of Vienna

Sunlight-induced carcinogenesis: Angiogenesis in skin cancer progression

Dr Olga V Volpert’s work on sunlight-induced carcinogenesis at the MD Anderson Cancer Center is explored here, including why angiogenesis is critically important in skin cancer progression

Modernising welfare payments in the UK

Director of Public Sector at Mastercard, Sam Mazloum explores why modernising welfare payments can be transformative for government and service user – and is not as difficult as it sounds

How to screen for endocrine disrupting chemicals (EDC)

Alberto Mantovani from Istituto Superiore di Sanità, Rome, Italy explains how to screen for endocrine disrupting chemicals (EDC)

Making all the difference: Construction and concessions in Europe

Eiffage is a major European player in construction and concessions, as this insightful article by the company explains

Self-reinforced gluten polymers: A step towards a true biocomposite

Prof Mikael S Hedenqvist and Dr Oisik Das from KTH Royal Institute of Technology in Sweden explain self-reinforced gluten polymers and why they are a step towards a true biocomposite

Wildlife conservation: Africa leading the way at the European Parliament

There are “winners” and “losers” in the conservation of wildlife in Africa! H.E. the Ambassador of Zimbabwe proclaimed in a conference

Accelerating innovative treatment for type 2 diabetes

Researchers from the University of Oxford and Novo Nordisk are collaborating to develop better treatments for type 2 diabetes

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders